ENANTA PHARMACEUTICALS INC Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Enanta Pharmaceuticals Inc Return On Equity for the quarter ending June 30, 2024 was -63.8 %, a 36.3% decline year-over-year.
  • Enanta Pharmaceuticals Inc annual Return On Equity for 2023 was -52.2 %, a 50.4% decline from 2022.
  • Enanta Pharmaceuticals Inc annual Return On Equity for 2022 was -34.7 %, a 87.4% decline from 2021.
  • Enanta Pharmaceuticals Inc annual Return On Equity for 2021 was -18.5 %, a 144% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -52.2 -17.5 -50.4% Oct 1, 2022 Sep 30, 2023
2022 -34.7 -16.2 -87.4% Sep 30, 2021 Sep 30, 2022
2021 -18.5 -10.9 -144% Oct 1, 2020 Sep 30, 2021
2020 -7.6 -18.1 -173% Oct 1, 2019 Sep 30, 2020
2019 10.5 -10 -48.9% Oct 1, 2018 Sep 30, 2019
2018 20.5 +14 +217% Oct 1, 2017 Sep 30, 2018
2017 6.46 -1.64 -20.2% Oct 1, 2016 Sep 30, 2017
2016 8.1 -27.7 -77.4% Oct 1, 2015 Sep 30, 2016
2015 35.8 +8.74 +32.3% Oct 1, 2014 Sep 30, 2015
2014 27.1 Oct 1, 2013 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.